With regard to Neu, I think the market had a higher expectation of a fail for their drug in the phase 3.
Neu have a history of failing drugs trials, so that didn't help.
But I'm not sure Neu is a good company to compare with anyway.
Their drug shows some life style improvement in people with Retts syndrome.
Ptx are fighting a nasty cancer in people who have pretty much no option left.
Hence ptx100 would garner a vastly higher price for their drug (100x maybe). And it's a drug that is really needed.
PTX Media related, page-1044
-
- There are more pages in this discussion • 570 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
